ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 901–1,000 of 1,001
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
Chen, M., Zhou, Y., Bao, K., Chen, S., Song, G., & Wang, S.-L. (2025) · BioDrugs · doi:10.1007/s40259-025-00712-6 · Cited by 17
Molecular Classification of Primary Immunodeficiencies of T Lymphocytes
Comrie, W. A., & Lenardo, M. J. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.02.003 · Cited by 16
Yan, X., Gu, Y., Wang, C., Sun, S., Wang, X., Tian, J., Wang, M., Ji, X., Duan, X., Gao, H., et al. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.07.011 · Cited by 16
Okamoto, R., Iritani, K., Amazaki, Y., Zhao, D., Chandrashekar, C., Maki, Y., Kanemitsu, Y., Kaino, T., & Kajihara, Y. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c02031 · Cited by 16
Periarticular metal hypersensitivity complications of hip bearings containing cobalt–chromium
Wu, D., Bhalekar, R. M., Marsh, J. S., Langton, D., & Stewart, A. J. (2022) · EFORT Open Reviews · doi:10.1530/eor-22-0036 · Cited by 16
“BHR (n = 64) Mean follow-up: 49 months (10-121) 10.”
BackgroundLischke, T., Hegemann, A., Gurka, S., Van, D. V., Burmeister, Y., Lam, K., Kershaw, O., Mollenkopf, H., Mages, H. W., Hutloff, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102034 · Cited by 16
Self-citationMoore, T. V., Clay, B. S., Cannon, J. L., Histed, A., Shilling, R. A., & Sperling, A. I. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0466oc · Cited by 16
Co-signals in organ transplantation
Dürrbach, A., François, H., Jacquet, A., Beaudreuil, S., & Charpentier, B. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32833c1369 · Cited by 16
Kamei, N., Fukui, R., Suzuki, Y., Kajihara, Y., Kinoshita, M., Kakehi, K., Hojo, H., Tezuka, K., & Tsuji, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.098 · Cited by 16
“ICOS is an inducible costimulatory receptor localized on the cell surface of activated T-cells [11].”
BackgroundInfluentialFurther study of anti-ICOS immunotherapy for rat cardiac allograft rejection
Xuan-Chao, P., Guo, L., Deng, Y., Naruse, K., Kimura, H., Sugawara, Y., & Makuuchi, M. (2008) · Surgery Today · doi:10.1007/s00595-007-3734-y · Cited by 16
“ICOS (Inducible costimulator) is the third member of the CD28 superfamily, which is structurally analogous with CD28 and CTLA-4.”
BackgroundSathkumara, H. D., Silva, N. R. D., Handunnetti, S. M., & Silva, A. D. D. (2015) · International Journal of Immunogenetics · doi:10.1111/iji.12217 · Cited by 16
Cheng, H.-Y., Tay, S., Wen, C.-J., Lin, C.-F., Wang, A. Y. L., Shih, L.-Y., Liu, S.-C., Kobayashi, E., Lin, C., & Wei, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203624 · Cited by 16
Lee, W., Huang, J., Kuo, M., Lin, S., Chen, L., Chen, M.-T., & Jaing, T. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60569-8 · Cited by 16
Mushtaq, M. U., DiPersio, J. F., Azzi, J. M., Cooper, B., Koehne, G., Koura, D. T., Maakaron, J. E., Magenau, J. M., McClune, B. L., Rimando, J. C., et al. (2026) · Blood · doi:10.1182/blood.2025031053 · Cited by 15
IGF1R signalling is a guardian of self-tolerance restricting autoantibody production
Erlandsson, M. C., Erdogan, S., Wasén, C., Andersson, K., Silfverswärd, S. T., Pullerits, R., Bemark, M., & Bokarewa, M. I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958206 · Cited by 15
“Since ICOSL-ICOS interaction stimulates the secretion of many cytokines (44), we analysed supernatants of LPS-activated 0 20 40 60 80 p=4.”
BackgroundHe, M., & Borlak, J. T. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00373-5 · Cited by 15
“Specifically, the inducible T cell co-stimulator (Icos) is expressed on activated CD4 + and CD8 + T cells [194], but not on resting T cells, and Icos is rapidly induced after TCR and Cd28 activation [195].”
BackgroundMeng, X., Xu, H., Liang, Y., Liang, M., Song, W., Zhou, B., Shi, J., Du, M., & Gao, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1334886 · Cited by 17
“ICOS is part of the CD28 superfamily and interacts with its ligand, ICOSL, found on antigen-presenting cells (40 – 42).”
Jamal, M. E., & Shibli, F. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00136 · Cited by 16
Novel Checkpoints and Cosignaling Molecules in Cancer Immunotherapy
Giuroiu, I., & Weber, J. S. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000241 · Cited by 16
DeBerg, H. A., Konecny, A., Shows, D. M., & Lord, J. D. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200009 · Cited by 16
Chen, D., Lin, W.-T., & Yu, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946456 · Cited by 15
“It is essential for the activation of T cells and further promotes the humoral immune response (12).”
BackgroundImmunotherapy for head and neck cancer: Fundamentals and therapeutic development
Okano, S. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2024.05.001 · Cited by 15
Larimore, K., Liang, L., Bakkour, S., & Sha, W. C. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-29 · Cited by 15
Hou, Y., Lin, X., Fu, S., Zhang, X., Liu, J., Liu, H., Lv, B., & Cui, H. Z. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-1023-0 · Cited by 15
Kunishige, T., Taniguchi, H., Terada, M., Akiba, H., Yagita∥, H., Abe, R., & Hori, J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20644 · Cited by 15
IL-7 and CD4 T Follicular Helper Cells in HIV-1 Infection
Chiodi, F., Bekele, Y., Lantto, R., & Nasi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00451 · Cited by 15
Tremble, L. F., O'Brien, M. A., Forde, P. F., & Soden, D. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.081 · Cited by 15
Iiyama, R., Kanai∥, T., Uraushihara, K., Totsuka, T., Nakamura, T., Miyata, T., Yagita∥, H., Kushi, A., Suzuki, K., Tezuka, K., et al. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00054-3 · Cited by 15
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 18
Nicholson, S. M., Carlesso, G., Cheng, L., Cook, H., Dacosta, K., Leininger, J. R., McKeever, K., Scott, S., Taylor, D. K., Streicher, K. L., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.08.018 · Cited by 15
Induction of Follicular-Like CXCR5 + CD8 + T Cells by TGF- β 1/IL-23 Is Limited During HIV Infection
Perdomo-Celis, F., Feria, M. G., Taborda, N. A., & Rugeles, M. T. (2019) · Viral Immunology · doi:10.1089/vim.2019.0029 · Cited by 16
“Consistent with previous reports (1,6,25), the stimulation with anti-CD3/CD28 antibodies increased the frequency of total CD8 + T cells expressing ICOS, CD40L, and PD-1 and/or their respective MeFI (Supplementary Fig.”
ICOS Contributes to T Cell Expansion in CTLA-4 Deficient Mice
van Berkel, M. E. A. T., Schrijver, E. H. R., Hofhuis, F. M., Sharpe, A. H., Coyle, A. J., Broeren, C. P. M., Tesselaar, K., & Oosterwegel, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.182 · Cited by 16
ICOS costimulation in inflammatory bowel disease
Kanai∥, T., Totsuka, T., Tezuka, K., & Watanabe, M. (2002) · Journal of Gastroenterology · doi:10.1007/bf03326419 · Cited by 15
CD99 Costimulation Up-Regulates T Cell Receptor-mediated Activation of JNK and AP-1
Yoon, S. S., Kim, H. J., Chung, D. H., & Kim, T. J. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13100-1 · Cited by 15
Learning to Remember: Generation and Maintenance of T-Cell Memory
Champagne, P., Dumont, A. R., & Sékaly, R. (2001) · DNA and Cell Biology · doi:10.1089/104454901753438561 · Cited by 16
ICOS Costimulation: Is It the Key to Selective Immunotherapy?
Sperling, A. I. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5084 · Cited by 15
Immune checkpoints in rheumatoid arthritis: progress and promise
Small, A., Lowe, K., & Wechalekar, M. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285554 · Cited by 14
Berrón‐Ruiz, L., López‐Herrera, G., Vargas‐Hernández, A., Santos‐Argumedo, L., López-Macías, C. I. R., Isibasi, A., Segura-Méndez, N. H., & Bonifaz, L. C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.013 · Cited by 15
YAMASHITA, M., Tasaki, M., Murakami, R., Arai, Y., Nakamura, T., & Nakao, S. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.01.016 · Cited by 14
“ICOS is a major marker of CD4 follicular helper T (TFH) cells, which are crucial for the humoral immune response in secondary lymphoid organs.(17) A subset of CD8 T cells in chronic viral infection reportedly expresses ICOS together with CXCR5, also a known marker of TFH cells, and shows minimal granzyme B expression.”
BackgroundThe role of ICOS in allergic disease: Positive or Negative?
Zhang, X., Hu, X., Tian, T., & Pang, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108394 · Cited by 16
Yang, M. S., Tian, S., Lin, Z., Fu, Z., & Li, C. (2022) · Medicine · doi:10.1097/md.0000000000031667 · Cited by 14
“2, B7-H2 mainly induces the production of the anti-inflammatory cytokine IL-10 instead of IL-2 by T cells, suggesting an immune regulatory role for B7-H2-ICOS.”
BackgroundParenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
Monge, C., Stoppa, I., Ferraris, C., Bozza, A., Battaglia, L., Cangemi, L., Miglio, G., Pizzimenti, S., Clemente, N., Gigliotti, C. L., et al. (2022) · Nanomaterials · doi:10.3390/nano12234233 · Cited by 14
Immune checkpoint molecules in prevention and development of asthma
Kanannejad, Z., Soleimanian, S., Ghahramani, Z., Sepahi, N., Mohkam, M., Alyasin, S. S., & Kheshtchin, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1070779 · Cited by 16
“The inducible co-stimulator (ICOS), known as the third member of the CD28 family (59), is an activating co-stimulatory immune checkpoint expressed on activated T cells as well as Treg cells (60, 61).”
BackgroundWang, F., Zhu, W., Liu, T., Sun, Z., Ju, S., Ju, S., Yu, G., Xie, W., Deng, Z., Lu, B., et al. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00706.x · Cited by 16
Sakthivel, P., Gereke, M., Breithaupt, A., Fuchs, D., Gigliotti, C. L., Gruber, A. D., Dianzani, U., & Bruder, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100970 · Cited by 14
Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation
Chen, Y., Liu, H., Liu, Z., Liang, S., Chen, J., Long, F., Peng, Y., Yan, L., & Gong, J. (2009) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.09.014 · Cited by 14
“The recipients were ivided into 3 groups (n 12 each): (1) the interference roup (a single intraportal infusion of BN lymphocytes ransfected with 1 mL interference plasmid pICOS-A, 10(7) cells/mL); (2) the rejection group (a single ntraportal infusion of BN lymphocytes transfected with mL empty vector pGenesil-2 cells/…”
BackgroundMethodThomos, M., Wurzel, P., Scharf, S., Koch, I., & Hansmann, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242177 · Cited by 14
“Additional factors like CXCL13, BCL6, ICOS and PD1 promote T-cell differentiation and germinal centre entry [10, 11].”
BackgroundPerry, D. J., Peters, L. D., Lakshmi, P. S., Zhang, L., Han, Z., Wasserfall, C. H., Mathews, C. E., Atkinson, M. A., & Brusko, T. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000708 · Cited by 14
Tfh Cell Differentiation and Their Function in Promoting B-Cell Responses
Qi, H., Chen, X., Chu, C., Liu, D., Ma, W., Wang, Y., Wu, L., Yan, H., & Yan, J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_6 · Cited by 15
Quiroga, M. F., Jurado, J. O., Martínez, G., Pasquinelli, V., Musella, R. M., Abbate, E. H., Issekutz, A. C., Bracco, M. M., Malbrán, A., Sieling, P. A., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/522522 · Cited by 14
The role of immune checkpoint molecules in cancers
Zhang, M., Xu, J., Zheng, Z., Guo, Z., Wang, H., Zhou, M., Tang, H., & Zhu, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1674818 · Cited by 18
Prominent Targets for Cancer Care: Immunotherapy Perspective
Patel, M. M., Thakkar, A., Bhatt, P. R., Shah, U., Patel, A. D., Solanki, N. D., Patel, S., Patel, S., Gandhi, K., & Patel, B. A. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230306121408 · Cited by 18
Meidenbauer, J., Wachter, M., Schulz, S. R., Mostafa, N., Zülch, L., Frey, B., Fietkau, R., Gaipl, U. S., & Jost, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1460150 · Cited by 15
Colino, J., Duke, L., & Snapper, C. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300722 · Cited by 13
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
Qin, X., Sun, W., Wang, C., Li, M., Ζhao, X., Li, C., & Zhang, H. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00800-6 · Cited by 13
Bekele, Y., Amu, S., Bobosha, K., Lantto, R., Nilsson, A., Endale, B., Gebre, M., Aseffa, A., Réthi, B., Howe, R., et al. (2015) · Medicine · doi:10.1097/md.0000000000001125 · Cited by 13
Blockade of CD70–CD27 Interaction Inhibits Induction of Allergic Lung Inflammation in Mice
Makino, F., Ito, J., Abe, Y., Harada, N., Kamachi, F., Yagita∥, H., Takahashi, K., Okumura, K., & Akiba, H. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0354oc · Cited by 13
Usui, Y., Takeuchi, M., Yamakawa, N., Takeuchi, A., Kezuka, T., Ma, J., Matsuda, R., Okunuki, Y., Akiba, H., & Gotô, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5286 · Cited by 13
“The CD28 homolog inducible costimulator (ICOS) has recently been identified as a novel member of the CD28 costimulator family and is expressed by activated T cells in both humans and mice.(19,20) The ICOS ligand, B7-related protein (B7RP-1), also known as B7 homologous protein (B7h), is constitutively expressed by den…”
BackgroundNovel gene therapeutic strategies for the induction of tolerance in cornea transplantation
Ritter, T., & Pleyer, U. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.59 · Cited by 14
Bian, Y., Shin-ichiro, H., Tomura, M., Zhou, X.-Y., Yashiro–Ohtani, Y., Mori, Y., Shimizu, J., Ono, S., Dunussi‐Joannopoulos, K., Wolf, S., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh188 · Cited by 13
Human T Follicular Helper Cells in Primary Immunodeficiency: Quality Just as Important as Quantity
Ma, C. S. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0257-6 · Cited by 14
O’Dwyer, R., Kovaleva, M., Zhang, J., Steven, J., Cummins, E., Luxenberg, D. P., Darmanin-Sheehan, A., Carvalho, M. F., Whitters, M. J., Saunders, K. C., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/4089459 · Cited by 14
Dotzler, B. (2011) · Brill | Fink eBooks · doi:10.30965/9783846751794_010 · Cited by 13
Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC
Olaoba, O. T., Ligali, F. C., Alabi, Z. O., Akinyemi, A. O., & Ayinde, K. S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188483 · Cited by 14
Targeting of Costimulatory Molecules as a Therapeutic Approach in Inflammatory Bowel Disease
Maerten, P., Liu, Z., & Ceuppens, J. L. (2003) · BioDrugs · doi:10.2165/00063030-200317060-00003 · Cited by 13
A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization
Long, C. M., Marshall, N. B., Lukomska, E., Kashon, M. L., Meade, B. J., Shane, H. L., & Anderson, S. E. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw074 · Cited by 13
Costimulation Blockade in Transplantation
Yeung, M. Y., Grimmig, T., & Sayegh, M. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_10 · Cited by 13
Prasad, D. V. R., Parekh, V. V., Joshi, B. N., Banerjee, P. P., Parab, P. B., Chattopadhyay, S., Kumar, A., & Mishra, G. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1801 · Cited by 13
Lin, F., Peng, Y., Jones, L. A., Verardi, P. H., & Yilma, T. D. (2008) · Journal of Virology · doi:10.1128/jvi.01870-08 · Cited by 15
T cell activation: you can't get good help
Linsley, P. S. (2001) · Nature Immunology · doi:10.1038/84233 · Cited by 13
Fukushima, A., Yamaguchi, T., Ishida, W., Fukata, K., Yagita∥, H., & Ueno, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.177 · Cited by 13
Sahinoglu, M., Sargın, G., Yavaşoğlu, İ., & Şentürk, T. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01286-9 · Cited by 12
“…assessed the relationship between Tfh cells and skin involvement, which is a characteristic feature of SSc. Previous studies have reported Tfh-like cell infiltrates in skin lesions of SSc patients, and these infiltrates were positively associated with the severity of skin involvement [18, 22, 23].”
BackgroundLu, J., Zhou, H., Chen, Y., Xia, X., Yang, J., Ma, J., Tian, J., & Wang, S. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103235 · Cited by 13
Costimulation Immunotherapy in Infectious Diseases
Mir, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802585-7.00003-0 · Cited by 13
Kim, H. J., Ji, Y. R., Kim, M. O., Yu, D. H., Shin, M. J., Yuh, H. S., Bae, K. B., Park, S. J., Yi, J. K., Kim, N. R., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.101 · Cited by 12
Taghavi, B. A., Alizadeh, N., Saeedi, H., Ahangar, N. K., Derakhshani, A., Hajiasgharzadeh, K., Silvestris, N., Baradaran, B., & Brunetti, O. (2022) · Molecules · doi:10.3390/molecules27113545 · Cited by 12
“ICOS plays a considerable role in regulating Th1 and Th2 cytokines during infection [48].”
BackgroundCAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Taheri, M. M., Javan, F., Poudineh, M., & Athari, S. S. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08998-0 · Cited by 12
“ICOS, a co-stimulatory receptor belonging to the CD28 family, plays a critical role in T cell survival and function [289, 290].”
Hodgson, R., Christiansen, D., Ziolkowski, A., Mouhtouris, E., Simeonovic, C. J., Ierino, F. L., & Sandrin, M. S. (2011) · Transplantation · doi:10.1097/tp.0b013e31821774e0 · Cited by 13
Gang, C., Jiahui, Y., Wang, H., Qing, C., Dongbao, Z., & Qian, S. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.03.016 · Cited by 12
O’Neill, N. A., Zhang, T., Braileanu, G., Cheng, X., Hershfeld, A. V., Sun, W., Reimann, K. A., Dahi, S., Kubicki, N. S., Hassanein, W., et al. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000761 · Cited by 12
Costimulation Immunotherapy in Allergies and Asthma
Mir, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802585-7.00004-2 · Cited by 12
Wang, F., Yan, T., Chen, L., Chen, X., Liu, T., Shen, S., Gao, L., Gao, L., Wang, T., Sun, J., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9711-2 · Cited by 12
Gene Therapy Approaches to Prevent Corneal Graft Rejection: Where Do We Stand?
Ritter, T., Wilk, M. M., & Nosov, M. (2013) · Ophthalmic Research · doi:10.1159/000350547 · Cited by 12
Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections
Zhou, D., & Ertl, H. C. J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.1.63 · Cited by 12
Tolerance Mechanisms in the Late Phase of the Antibody Response
Goodnow, C. C., Campbell, J. A., Rui, L., & Vinuesa, C. G. (2007) · Springer eBooks · doi:10.1007/0-387-46530-8_15 · Cited by 12
Youngnak‐Piboonratanakit, P., Tsushima, F., Otsuki, N., Igarashi, H., Omura, K., & Azuma, M. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01726.x · Cited by 12
Li, P., Jin, Y., Zhao, R. Z., Xue, Z., & Ji, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12864 · Cited by 11
Nikanjam, M., Kato, S., Nishizaki, D., Miyashita, H., Pabla, S., Nesline, M., Ko, H. C., Conroy, J. M., Naing, A., & Kurzrock, R. (2025) · Cancer Medicine · doi:10.1002/cam4.71467 · Cited by 12
“Tregs suppress immune responses and help the tumor evade the immune response (Figure 1) [9, 31, 32, 34, 41–42].”
InfluentialLu, X., Zhang, X., Cheung, A. K. L., Moog, C., Xia, H., Li, Z., Wang, R., Ji, Y., Xia, W., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837921 · Cited by 11
“ICOS is expressed on activated T cells (46, 47), therefore, we analyzed the expression level of cell cycling marker Ki-67 on cTfh cells.”
BackgroundResultKülp, M., Siemund, A. L., Larghero, P., Dietz, A., Alten, J., Cario, G., Eckert, C., Caye‐Eude, A., Cavé, H., Bardini, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104613 · Cited by 13
Zhou, A., Shi, C., Fan, Y., Zheng, Y., Wang, J., Liu, Z., Xie, H., Liu, J., & Jiao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171308 · Cited by 11
“reported that there is no ICOS expression on granulocytes using F44 (specific monoclonal antibody to ICOS) (60).”
MethodMeziani, L., de Thoré, M. G., Clémenson, C., Liu, W., Laurent, P.-A., Mondini, M., Vozenin, M., & Deutsch, É. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006846 · Cited by 11
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction
Abdel‐Rahman, S. A., Santini, B. L., Calvo‐Barreiro, L., Zacharias, M., & Gabr, M. T. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129599 · Cited by 12
NADPH Oxidase has a Regulatory Role in Acute Allergic Asthma
Banerjee, E. R., & Henderson, W. R. (2011) · Cited by 11
Overview of Basic Immunology and Clinical Application
Stephen, B., & Hajjar, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41008-7_1 · Cited by 13
Harlan, L. M., Chan, M. A., & Benedict, S. H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.008 · Cited by 11
Okano, K., Nitta, K., Ogawa, S., Horita, S., Habiro, K., Nihei, H., & Abe, R. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.06.004 · Cited by 11
Rummel, T., Batchelder, J. M., Flaherty, P. R., LaFleur, G., Nanavati, P., Burns, J. M., & Weidanz, W. P. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5768-5774.2004 · Cited by 13
Cuzzola, M., Fiasché, M., Iacopino, P., Messina, G., Martino, M. V., Console, G., Fedele, R., Massi, D., Recchia, A. G., Irrera, G., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.059980 · Cited by 11
Graves, S. S., Parker, M. H., Stone, D. M., Sale, G. E., Pillai, S. P. S., Johnson, M. M., & Storb, R. F. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.09.010 · Cited by 11
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.